| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80053 |
Comprehensive metabolic panel |
40,721 |
34,818 |
$4.89M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
78,520 |
71,355 |
$4.54M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
23,577 |
22,331 |
$1.57M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
7,843 |
7,466 |
$1.53M |
| 36415 |
Collection of venous blood by venipuncture |
4,750 |
4,413 |
$1.06M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
33,450 |
29,987 |
$821K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
2,059 |
1,741 |
$792K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13,055 |
12,336 |
$757K |
| J3490 |
Unclassified drugs |
2,519 |
2,336 |
$611K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,075 |
5,825 |
$533K |
| 87070 |
|
4,728 |
4,537 |
$462K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
16,084 |
13,341 |
$441K |
| 71046 |
Radiologic examination, chest; 2 views |
12,240 |
11,554 |
$423K |
| 81001 |
|
24,851 |
22,577 |
$370K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
11,327 |
10,366 |
$344K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
5,755 |
5,498 |
$332K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
589 |
575 |
$318K |
| 81003 |
|
12,181 |
11,306 |
$295K |
| 73610 |
|
2,958 |
2,751 |
$292K |
| 86756 |
|
2,820 |
2,716 |
$284K |
| 82565 |
|
1,222 |
1,056 |
$284K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,072 |
7,587 |
$262K |
| 71045 |
Radiologic examination, chest; single view |
14,518 |
13,243 |
$242K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,499 |
7,161 |
$241K |
| 73130 |
|
2,336 |
2,154 |
$228K |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,463 |
6,000 |
$216K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
1,095 |
603 |
$213K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
20,940 |
18,538 |
$211K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,121 |
6,207 |
$209K |
| 73562 |
|
2,832 |
2,564 |
$208K |
| 73630 |
|
2,956 |
2,718 |
$202K |
| 85027 |
|
49,502 |
40,227 |
$163K |
| 73110 |
|
1,732 |
1,589 |
$155K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
7,518 |
7,078 |
$149K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,013 |
4,478 |
$149K |
| 12011 |
|
835 |
793 |
$135K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
169 |
163 |
$130K |
| 10060 |
|
894 |
840 |
$125K |
| 73030 |
|
1,738 |
1,609 |
$122K |
| 12001 |
|
846 |
811 |
$122K |
| 74018 |
|
1,917 |
1,807 |
$119K |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
1,437 |
1,244 |
$118K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,141 |
2,951 |
$116K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,160 |
1,115 |
$113K |
| 81025 |
|
16,789 |
15,518 |
$112K |
| 84702 |
|
3,522 |
2,958 |
$109K |
| G0378 |
Hospital observation service, per hour |
4,825 |
3,689 |
$94K |
| 87210 |
|
2,170 |
2,089 |
$93K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,545 |
3,405 |
$92K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
271 |
259 |
$87K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,343 |
2,226 |
$85K |
| 73080 |
|
930 |
886 |
$75K |
| 87077 |
|
2,227 |
2,107 |
$75K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
2,055 |
1,949 |
$73K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
498 |
493 |
$72K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
546 |
509 |
$62K |
| 73140 |
|
413 |
387 |
$55K |
| 72100 |
|
982 |
937 |
$53K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
430 |
401 |
$50K |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
524 |
485 |
$49K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
10,846 |
9,231 |
$46K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,570 |
7,518 |
$43K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
834 |
783 |
$40K |
| 29125 |
|
642 |
606 |
$39K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
211 |
201 |
$38K |
| 73502 |
|
751 |
711 |
$35K |
| 73590 |
|
701 |
611 |
$35K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,098 |
4,556 |
$33K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,724 |
1,627 |
$33K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
656 |
277 |
$33K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
17,921 |
13,191 |
$33K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,359 |
1,707 |
$30K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
756 |
750 |
$30K |
| 84484 |
|
13,931 |
10,976 |
$30K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
18,469 |
15,870 |
$30K |
| 93971 |
|
698 |
662 |
$29K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
968 |
934 |
$28K |
| 59025 |
Fetal non-stress test |
1,964 |
1,503 |
$28K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
439 |
413 |
$28K |
| 84703 |
|
3,894 |
3,677 |
$28K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
14,025 |
11,941 |
$27K |
| 73090 |
|
448 |
414 |
$27K |
| 82803 |
|
696 |
618 |
$24K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,853 |
1,557 |
$22K |
| 86850 |
|
2,063 |
1,913 |
$21K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,364 |
2,848 |
$18K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
442 |
429 |
$17K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
179 |
173 |
$14K |
| 84439 |
|
1,341 |
1,271 |
$14K |
| 76801 |
|
411 |
383 |
$14K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
5,759 |
4,389 |
$13K |
| 76770 |
|
115 |
108 |
$12K |
| 96376 |
|
1,826 |
1,569 |
$12K |
| 93017 |
|
391 |
378 |
$11K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,139 |
1,943 |
$11K |
| 76642 |
|
148 |
143 |
$11K |
| 71250 |
|
135 |
125 |
$11K |
| 86140 |
|
2,006 |
1,811 |
$11K |
| 83690 |
|
11,271 |
10,149 |
$10K |
| 85379 |
|
1,616 |
1,528 |
$9K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,884 |
3,687 |
$9K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,345 |
6,134 |
$8K |
| 80061 |
Lipid panel |
2,110 |
2,031 |
$8K |
| 83880 |
|
2,903 |
2,614 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,891 |
1,608 |
$8K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,033 |
577 |
$8K |
| 72170 |
|
684 |
643 |
$8K |
| 72040 |
|
99 |
93 |
$7K |
| 85007 |
|
1,309 |
1,180 |
$7K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
400 |
302 |
$7K |
| 70486 |
|
213 |
202 |
$7K |
| 82042 |
|
442 |
411 |
$6K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,951 |
1,547 |
$6K |
| 12002 |
|
76 |
70 |
$6K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
28 |
27 |
$6K |
| 86900 |
|
3,507 |
3,247 |
$6K |
| 76830 |
Ultrasound, transvaginal |
196 |
191 |
$6K |
| J7050 |
Infusion, normal saline solution, 250 cc |
551 |
477 |
$6K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,324 |
988 |
$5K |
| 80076 |
|
70 |
66 |
$5K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,932 |
5,655 |
$5K |
| 73560 |
|
138 |
114 |
$5K |
| 83605 |
|
3,652 |
3,223 |
$5K |
| 83735 |
|
13,701 |
11,716 |
$5K |
| 85610 |
|
4,746 |
4,258 |
$5K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
282 |
258 |
$5K |
| J2060 |
Injection, lorazepam, 2 mg |
1,295 |
1,111 |
$5K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,596 |
2,283 |
$5K |
| 82247 |
|
467 |
404 |
$5K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
271 |
261 |
$4K |
| 87040 |
|
2,835 |
2,269 |
$4K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
47 |
43 |
$4K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
12 |
12 |
$4K |
| J1815 |
Injection, insulin, per 5 units |
1,007 |
539 |
$3K |
| 72070 |
|
52 |
51 |
$3K |
| 73620 |
|
86 |
76 |
$3K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,395 |
2,166 |
$3K |
| 71101 |
|
47 |
44 |
$3K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
529 |
406 |
$3K |
| 84100 |
|
1,777 |
1,494 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
708 |
659 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,491 |
3,352 |
$2K |
| 80074 |
|
12 |
12 |
$2K |
| C1769 |
Guide wire |
390 |
353 |
$2K |
| 73552 |
|
49 |
49 |
$2K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
695 |
620 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,874 |
1,792 |
$2K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
12 |
12 |
$2K |
| 73660 |
|
12 |
12 |
$2K |
| 87186 |
|
2,092 |
1,977 |
$1K |
| 15853 |
|
27 |
25 |
$1K |
| 76820 |
|
32 |
12 |
$1K |
| 72110 |
|
37 |
37 |
$1K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
13 |
13 |
$1K |
| 70491 |
|
12 |
12 |
$1K |
| 72131 |
|
26 |
26 |
$947.95 |
| 82270 |
|
31 |
30 |
$897.03 |
| 77066 |
Tomosynthesis, mammo |
12 |
12 |
$882.62 |
| 82550 |
|
98 |
84 |
$882.15 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
27 |
26 |
$812.80 |
| 86901 |
|
3,507 |
3,247 |
$735.17 |
| 73600 |
|
16 |
13 |
$703.13 |
| 80047 |
|
14 |
13 |
$695.30 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
977 |
577 |
$676.24 |
| 76870 |
|
13 |
13 |
$602.97 |
| 85730 |
|
3,208 |
2,894 |
$552.31 |
| 82977 |
|
518 |
487 |
$535.76 |
| 90714 |
|
683 |
657 |
$484.88 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
5,639 |
5,340 |
$464.76 |
| 86308 |
|
16 |
14 |
$426.92 |
| 88304 |
|
428 |
417 |
$421.66 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,083 |
981 |
$333.15 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
753 |
664 |
$325.23 |
| 36000 |
|
140 |
138 |
$274.09 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
162 |
156 |
$250.01 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
358 |
336 |
$249.26 |
| 93975 |
|
57 |
51 |
$218.24 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,203 |
1,130 |
$188.00 |
| 84450 |
|
375 |
349 |
$168.55 |
| 84436 |
|
12 |
12 |
$148.60 |
| J1630 |
Injection, haloperidol, up to 5 mg |
198 |
171 |
$39.35 |
| 83540 |
|
37 |
36 |
$35.49 |
| J2704 |
Injection, propofol, 10 mg |
866 |
762 |
$33.19 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
29 |
26 |
$31.42 |
| 90715 |
|
38 |
36 |
$28.69 |
| 85651 |
|
1,304 |
1,215 |
$25.52 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
851 |
770 |
$21.49 |
| 82150 |
|
507 |
475 |
$16.86 |
| 84460 |
|
373 |
347 |
$14.69 |
| 84075 |
|
365 |
340 |
$14.47 |
| 82009 |
|
116 |
104 |
$13.43 |
| A9270 |
Non-covered item or service |
3,512 |
1,353 |
$12.50 |
| 84155 |
|
363 |
338 |
$10.36 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
112 |
81 |
$6.21 |
| 85045 |
|
78 |
53 |
$5.03 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
72 |
54 |
$0.24 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
27 |
27 |
$0.00 |
| 82607 |
|
51 |
49 |
$0.00 |
| 70498 |
|
80 |
76 |
$0.00 |
| 41899 |
Unlisted procedure, dentoalveolar structures |
67 |
67 |
$0.00 |
| 86920 |
|
40 |
37 |
$0.00 |
| 82728 |
|
13 |
12 |
$0.00 |
| J0456 |
Injection, azithromycin, 500 mg |
31 |
29 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
15 |
15 |
$0.00 |
| 82746 |
|
14 |
14 |
$0.00 |
| A9698 |
Non-radioactive contrast imaging material, not otherwise classified, per study |
27 |
25 |
$0.00 |
| 87205 |
|
45 |
38 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
23 |
21 |
$0.00 |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
151 |
150 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
138 |
123 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
182 |
142 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
55 |
52 |
$0.00 |
| 82248 |
|
12 |
12 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
13 |
12 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
41 |
38 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
63 |
28 |
$0.00 |
| 83525 |
|
12 |
12 |
$0.00 |